000			02033 a2200553 4500
005			20250517021643.0
264		0	_c20150610
008			201506s 0 0 eng d
022			_a1527-7755
024	7		_a10.1200/JCO.2014.55.9880 _2doi
040			_aNLM _beng _cNLM
100	1		_aBell, Jessica L
245	0	0	_aIGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cApr 2015
300			_a1285-93 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aBiomarkers, Tumor _xgenetics
650	0	4	_aCell Line, Tumor
650	0	4	_aDatabases, Genetic
650	0	4	_aDisease-Free Survival
650	0	4	_aGene Amplification
650	0	4	_aGene Dosage
650	0	4	_aGene Expression Profiling _xmethods
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aN-Myc Proto-Oncogene Protein
650	0	4	_aNeoplasm Staging
650	0	4	_aNeuroblastoma _xgenetics
650	0	4	_aNuclear Proteins _xgenetics
650	0	4	_aOligonucleotide Array Sequence Analysis
650	0	4	_aOncogene Proteins _xgenetics
650	0	4	_aPhenotype
650	0	4	_aProportional Hazards Models
650	0	4	_aRNA, Messenger _xanalysis
650	0	4	_aRNA-Binding Proteins _xgenetics
650	0	4	_aRisk Factors
650	0	4	_aTime Factors
650	0	4	_aTransfection
650	0	4	_aTreatment Outcome
700	1		_aTurlapati, Raseswari
700	1		_aLiu, Tao
700	1		_aSchulte, Johannes H
700	1		_aHüttelmaier, Stefan
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 33 _gno. 11 _gp. 1285-93
856	4	0	_uhttps://doi.org/10.1200/JCO.2014.55.9880 _zAvailable from publisher's website
999			_c24690855 _d24690855